The three-dose New Crown vaccine is a recombinant subunit CHO vaccine that is effective against infection with the omicronjon strain and in reducing the rate of severe illness and mortality.
Although the immune escape ability of the Omicronjon variant strain of New Crown virus is stronger than that of the conventional virus, and the virus mutation may reduce the protective effect of the vaccine antibody, the protective effect of the New Crown vaccine still exists.
The vaccine remains immune to the vast majority of the mutated strains and remains effective in reducing the emergence of infection, severe illness and death.
The latest treatment guidelines in this country still include vaccination against new coronaviruses as an important part of neocoronavirus prophylaxis. Regardless of the vaccine, it is recommended that those who are eligible for vaccination receive it in a timely manner and throughout the course of the vaccination.
To receive the vaccine, it is recommended that you visit a specialized healthcare facility and get vaccinated under the guidance of a professional.